Abbott Labs to pay $160M over kickbacks, false diabetes claims
Business Insurance - Aug 02, 2021
Abbott Laboratories will pay $160 million to resolve claims that two of its units submitted false claims to Medicare by providing kickbacks to diabetes patients, including “free” or “no-cost” glucose monitors, the U.S. Department of Justice said....
Recommended Articles
Posted: Aug 22, 2023
South Korean insurers’ combined net profits increased to around 8 trillion South Korean won ($5.95 b...
Posted: Aug 22, 2023
According to a new report from Aon PLC, South Africa’s insurance market is continuing to see reduced...
Posted: Aug 22, 2023
Independent insurance brokerage Latin RE is the first Brazilian broker to get a license to operate d...